Review
Nature Reviews Cancer 7, 202-211 (March 2007) | doi:10.1038/nrc2087
Inhibiting transient protein–protein interactions: lessons from the Cdc25 protein tyrosine phosphatases
Johannes Rudolph1 About the author
Abstract
Transient protein–protein interactions have key regulatory functions in many of the cellular processes that are implicated in cancerous growth, particularly the cell cycle. Targeting these transient interactions as therapeutic targets for anticancer drug development seems like a good idea, but it is not a trivial task. This Review discusses the issues and difficulties that are encountered when considering these transient interactions as drug targets, using the example of the cell division cycle 25 (Cdc25) phosphatases and their cyclin-dependent kinase (CDK)–cyclin protein substrates.
- View At a Glance
Author affiliations
- Departments of Biochemistry and Chemistry, Duke University Medical Center, BOX 3813, LSRC Building, Room C125, Durham, North Carolina 27710, USA. Email: johannes@alum.mit.edu
Published online 8 February 2007
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Cell cycle Dual control of mitotic exitNature News and Views (11 Nov 1999)
Developmental quiescence: Cdc14 moonlighting in G1Nature Cell Biology News and Views (01 Aug 2004)
RESEARCH
A test of the role of the proximal histidines in the Perutz model for cooperativity in haemoglobinNature Structural Biology Article (01 Jan 1997)
Verification of enhancement of the CSF space, not parenchyma, in acute stroke patients with early blood?brain barrier disruptionJournal of Cerebral Blood Flow & Metabolism Brief Communication
See all 19 matches for Research